BANK VONTOBEL/CALL/EDWARDS LIFESCIENCES/65/0.1/20.09.24 | Delayed Deutsche Boerse AG 19:03:43 03/07/2024 BST | ||
| 2.52 EUR | 0.00% |
|
| Current month | -7.35% | ||
| 1 month | +11.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 03/07/24 | 2.52 | 0.00% |
| 02/07/24 | 2.52 | +2.02% |
| 01/07/24 | 2.47 | -9.19% |
| 28/06/24 | 2.72 | -1.45% |
| 27/06/24 | 2.76 | +6.56% |
Delayed Quote Deutsche Boerse AG
Last update July 03, 2024 at 07:03 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM8P1A |
| ISIN | DE000VM8P1A8 |
| Date issued | 18/01/2024 |
| Strike | 65 $ |
| Maturity | 20/09/2024 (79 Days) |
| Parity | 10 : 1 |
| Emission price | 1.4 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.08 € |
|---|---|
| Lowest since issue | 1.25 € |
| Spread | 0.01 € |
| Spread % | 0.39% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.13
USD
Spread / Average Target
+5.54%
- Stock Market
- Warrants
- Warrant
